$46.26
0.76 (+1.67%)
Gilead Sciences, Inc. (GILD)
CAPS Rating:
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.